Ardelyx Inc
Ardelyx Inc (ARDX) Implied Volatility Current
ARDX's 30 day implied volatility is 308.55%, with an IV Rank of 97.22%. This is a high IV Rank versus the past year, meaning Ardelyx Inc options are relatively expensive and currently favor sellers. ARDX's 30 day historical volatility sits at 53.22%, which means implied volatility is running 255.33 points above historical volatility, as of Nov 16, 2026.
Read more
Tracking ARDX implied volatility helps you spot when Ardelyx Inc options are historically cheap or expensive, and where the best trades are hiding. When ARDX IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor ARDX implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking ARDX IV rank helps you see whether ARDX's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →